These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 15553982)
21. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia]. Tanović A; Alfaro V Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529 [TBL] [Abstract][Full Text] [Related]
22. Recovery of NMDA receptor currents from MK-801 blockade is accelerated by Mg2+ and memantine under conditions of agonist exposure. McKay S; Bengtson CP; Bading H; Wyllie DJ; Hardingham GE Neuropharmacology; 2013 Nov; 74():119-25. PubMed ID: 23402996 [TBL] [Abstract][Full Text] [Related]
24. Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions. Jansen M; Dannhardt G Eur J Med Chem; 2003; 38(7-8):661-70. PubMed ID: 12932897 [TBL] [Abstract][Full Text] [Related]
25. BQ-869, a novel NMDA receptor antagonist, protects against excitotoxicity and attenuates cerebral ischemic injury in stroke. Yu G; Wu F; Wang ES Int J Clin Exp Pathol; 2015; 8(2):1213-25. PubMed ID: 25973006 [TBL] [Abstract][Full Text] [Related]
26. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. Liu Y; Wong TP; Aarts M; Rooyakkers A; Liu L; Lai TW; Wu DC; Lu J; Tymianski M; Craig AM; Wang YT J Neurosci; 2007 Mar; 27(11):2846-57. PubMed ID: 17360906 [TBL] [Abstract][Full Text] [Related]
27. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Lipton SA Nat Rev Drug Discov; 2006 Feb; 5(2):160-70. PubMed ID: 16424917 [TBL] [Abstract][Full Text] [Related]
28. The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain. Manning SM; Boll G; Fitzgerald E; Selip DB; Volpe JJ; Jensen FE Int J Dev Neurosci; 2011 Nov; 29(7):767-73. PubMed ID: 21624454 [TBL] [Abstract][Full Text] [Related]
29. Open-channel blockers of the NMDA receptor complex. Albensi BC; Ilkanich E Drug News Perspect; 2004 Nov; 17(9):557-62. PubMed ID: 15645013 [TBL] [Abstract][Full Text] [Related]
30. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360 [TBL] [Abstract][Full Text] [Related]
31. Memantine selectively blocks extrasynaptic NMDA receptors in rat substantia nigra dopamine neurons. Wu YN; Johnson SW Brain Res; 2015 Apr; 1603():1-7. PubMed ID: 25656790 [TBL] [Abstract][Full Text] [Related]
32. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data. Parsons CG; Danysz W; Quack G Neuropharmacology; 1999 Jun; 38(6):735-67. PubMed ID: 10465680 [TBL] [Abstract][Full Text] [Related]
33. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity. Cho Y; Ueda T; Mori A; Shimizu H; Haga Y; Yozu R J Vasc Surg; 2005 Oct; 42(4):765-71. PubMed ID: 16242566 [TBL] [Abstract][Full Text] [Related]
35. Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Kornhuber J; Weller M Biol Psychiatry; 1997 Jan; 41(2):135-44. PubMed ID: 9018383 [TBL] [Abstract][Full Text] [Related]
36. Protection from glutamate-induced excitotoxicity by memantine. Kutzing MK; Luo V; Firestein BL Ann Biomed Eng; 2012 May; 40(5):1170-81. PubMed ID: 22203191 [TBL] [Abstract][Full Text] [Related]
37. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]. Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678 [TBL] [Abstract][Full Text] [Related]